Back to search

United States· US:69097-820_b2d9319a-6c34-4851-8486-3d956e916f53

Zemdri (plazomicin)

A plazomicin product containing plazomicin, registered in United States by Cipla USA Inc..

ATC J01GB14US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedZemdri (plazomicin)ATCJ01GB14REGISTER NO.US:69097-820_b2d9319a…PACKS LISTED2CHECKEDSeptember 27, 2026

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
PLAZOMICIN
Manufacturer
Cipla USA Inc.
Country
United States (US)
ATC code
J01GB14
ATC class
Plazomicin
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    69097-820-96
  • ndc11
    6909782096
    10 VIAL in 1 CARTON (69097-820-96) / 10 mL in 1 VIAL (69097-820-37)

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

99 interactions on record for plazomicin.

Graded by severity as the source publishes them — 29 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Plazomicin · interactions on record

99 records

  • 29 severe
  • 68 moderate
  • 2 minor

Most severe, free to view

  • Magnesium sulfateA06AD04severe
  • MannitolA06AD16severe
  • Polymyxin BA07AA05severe
  • Magnesium sulfateA12CC02severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c1bdf283-f3bb-4b42-86c3-835cec56d4f5
GET /v1/drugs/c1bdf283-f3bb-4b42-86c3-835cec56d4f5?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "INTRAVENOUS",
  "source": "ndc",
  "strength": "500",
  "substance": "PLAZOMICIN",
  "productndc": "69097-820",
  "dosage_form": "INJECTION",
  "dea_schedule": null,
  "strength_unit": "mg/10mL",
  "application_number": "NDA210303",
  "marketing_category": "NDA"
}

See everything about plazomicin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.